Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The transforming growth factor-β (TGF-β) signalling pathway is a key mediator of fibroblast activation that drives the aberrant synthesis of extracellular matrix in fibrotic diseases. Here we demonstrate a novel link between transforming growth factor-β and the canonical Wnt pathway. TGF-β stimulates canonical Wnt signalling in a p38-dependent manner by decreasing the expression of the Wnt antagonist Dickkopf-1. Tissue samples from human fibrotic diseases show enhanced expression of Wnt proteins and decreased expression of Dickkopf-1. Activation of the canonical Wnt pathway stimulates fibroblasts in vitro and induces fibrosis in vivo. Transgenic overexpression of Dickkopf-1 ameliorates skin fibrosis induced by constitutively active TGF-β receptor type I signalling and also prevents fibrosis in other TGF-β-dependent animal models. These findings demonstrate that canonical Wnt signalling is necessary for TGF-β-mediated fibrosis and highlight a key role for the interaction of both pathways in the pathogenesis of fibrotic diseases. Aberrant activation of the TGF-β pathway leads to fibrotic disease. Distler and colleagues show that TGF-β-mediated fibrosis requires the decrease of Dickkopf-1, an antagonist of canonical Wnt signalling, suggesting that the two pathways interact for the manifestation of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGFβ signaling via p38 MAPK lowers dickkopf-1 (DKK1) expression (62), which is an inhibitor of canonical Wnt signaling via β-catenin. In skin and fibroblasts of SSc patients, decreased DKK1 expression is observed (62), together with increased β-catenin accumulation (63), and increased expression of Wnt signaling-related genes (62, 64).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Self-citationTowards an integrated view of Wnt signaling in development
van Amerongen, R., & Nusse, R. (2009) · Development · doi:10.1242/dev.033910 · Cited by 1,175
Wnt signaling in disease and in development
NUSSE, R. (2005) · Cell Research · doi:10.1038/sj.cr.7290260 · Cited by 973
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Bafico, A., Liu, G., Yaniv, A., Gazit, A., & Aaronson, S. A. (2001) · Nature Cell Biology · doi:10.1038/35083081 · Cited by 772
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
Wieser, R., Wrana, J. L., & Massagué, J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07214.x · Cited by 699
Wnt/β-Catenin Signaling Promotes Renal Interstitial Fibrosis
He, W., Dai, C., Li, Y., Zeng, G., Monga, S. P., & Liu, Y. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060566 · Cited by 549
Transforming growth factor-β and fibrosis
Verrecchia, F., & Mauviel, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i22.3056 · Cited by 510
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
Königshoff, M., Balsara, N., Pfaff, E.-M., Kramer, M., Chrobak, I., Seeger, W., & Eickelberg, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002142 · Cited by 507
Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis
Henderson, W. R., Chi, E. Y., Ye, X., Nguyen, C., Tien, Y.-T., Zhou, B., Borok, Z., Knight, D. A., & Kahn, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001520107 · Cited by 462
Denton (2007) · doi:10.1002/art.22289 · Cited by 447
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia
Li, J., Sarosi, I., Cattley, R. C., Pretorius, J., Asuncion, F., Grisanti, M., Morony, S., Adamu, S., Geng, Z., Qiu, W., et al. (2006) · Bone · doi:10.1016/j.bone.2006.03.017 · Cited by 441
Akiyama, T. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00011-3 · Cited by 425
Wnt/β-catenin signaling: new (and old) players and new insights
Huang, H., & He, X. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.009 · Cited by 419
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1013 · Cited by 414
Systemic and cell type-specific gene expression patterns in scleroderma skin
Whitfield, M. L., Finlay, D. R., Murray, J. I., Troyanskaya, O. G., Chi, J.-T., Pergamenschikov, A., McCalmont, T. H., Brown, P. O., Botstein, D., & Connolly, M. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635114100 · Cited by 409
The role of Dickkopf-1 in bone development, homeostasis, and disease
Pinzone, J. J., Hall, B. M., Thudi, N. K., Vonau, M., Qiang, Y.-W., Rosol, T. J., & Shaughnessy, J. D. (2009) · Blood · doi:10.1182/blood-2008-03-145169 · Cited by 408
Distler, J. H. W., Jüngel, A., Huber, L. C., Schulze‐Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gay, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22314 · Cited by 383
Self-citationWnt10b Inhibits Development of White and Brown Adipose Tissues
Longo, K. A., Wright, W. S., Kang, S., Gerin, I., Chiang, S.-H., Lucas, P. C., Opp, M. R., & MacDougald, O. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402937200 · Cited by 371
Self-citationR-Spondin Family Members Regulate the Wnt Pathway by a Common Mechanism
Kim, K.-A., Wagle, M., Tran, K., Zhan, X., Dixon, M. A., Liu, S., Gros, D., Korver, W., Yonkovich, S., Tomasevic, N., et al. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0187 · Cited by 342
Distler, J. H. W., Jüngel, A., Huber, L. C., Seemayer, C. A., Reich, C. F., Gay, R. E., Michel, B. A., Fontana, A., Gay, S., Pisetsky, D. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409781102 · Cited by 328
Self-citationNam, J.-S., Turcotte, T. J., Smith, P. F., Choi, S., & Yoon, J. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508324200 · Cited by 288
New Mechanisms of Pulmonary Fibrosis
Strieter, R. M., & Mehrad, B. (2009) · Chest · doi:10.1378/chest.09-0510 · Cited by 284
Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton.
Green, M. C., Sweet, H. O., & Bunker, L. E. (1976) · PubMed Central · Cited by 281
Platelet-derived serotonin links vascular disease and tissue fibrosis
Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101629 · Cited by 266
Self-citationHe, W., Zhang, L., Ni, A., Zhang, Z., Mirotsou, M., Mao, L., Pratt, R. E., & Dzau, V. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004708107 · Cited by 216
Wei, J., Melichian, D., Komura, K., Hinchcliff, M., Lam, A. P., Lafyatis, R., Gottardi, C. J., MacDougald, O. A., & Varga, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30312 · Cited by 214
Self-citationSonnylal, S., Denton, C. P., Zheng, B., Keene, D. R., He, R., Adams, H. P., VanPelt, C. S., Geng, Y. J., Deng, J. M., Behringer, R. R., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22328 · Cited by 198
Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts
Mori, Y., Chen, S., & Varga, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11157 · Cited by 194
Animal models of systemic sclerosis: Prospects and limitations
Beyer, C., Schett, G. A., Distler, O., & Distler, J. H. W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27647 · Cited by 187
Self-citationAkhmetshina, A., Dees, C., Pileckyte, M., Maurer, B., Axmann, R., Jüngel, A., Zwerina, J., Gay, S., Schett, G., Distler, O., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-105627 · Cited by 187
Self-citationSato, M. (2006) · Acta Dermato-Venereologica · doi:10.2340/00015555-0101 · Cited by 182
Wei, Q., Yokota, C., Semenov, M. V., Doble, B., Woodgett, J., & He, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701927200 · Cited by 182
SnapShot: Wnt/β-Catenin Signaling
MacDonald, B. T., Semenov, M. V., & He, X. (2007) · Cell · doi:10.1016/j.cell.2007.11.036 · Cited by 173
Spiera, R. F., Gordon, J. K., Mersten, J. N., Magro, C. M., Mehta, M., Wildman, H. F., Kloiber, S., Kirou, K. A., Lyman, S., & Crow, M. K. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143974 · Cited by 173
Systemic sclerosis: hypothesis-driven treatment strategies
Charles, C., Clements, P., & Furst, D. E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68737-0 · Cited by 169
A role for Wnt-4 in renal fibrosis
Surendran, K., McCaul, S. P., & Simon, T. C. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0009.2001 · Cited by 164
Cheon, S. S., Nadesan, P., Poon, R. W. M., & Alman, B. A. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.029 · Cited by 161
DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation
Semënov, M. V., Zhang, X., & He, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800014200 · Cited by 133
Akhmetshina, A., Dees, C., Pileckyte, M., Szucs, G., Spriewald, B. M., Zwerina, J., Distler, O., Schett, G., & Distler, J. H. W. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23677 · Cited by 120
Self-citationTargeted Disruption of the Wnt Regulator Kremen Induces Limb Defects and High Bone Density
Ellwanger, K., Saito, H., Clément-Lacroix, P., Maltry, N., Niedermeyer, J., Lee, W. K., Baron, R., Rawadi, G., Westphal, H., & Niehrs, C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00222-08 · Cited by 106
The role of Wnt proteins in arthritis
Schett, G. A., Zwerina, J., & David, J. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0881 · Cited by 96
Self-citationKopp, J., Preis, E., Said, H., Hafemann, B., Wickert, L., Gressner, A. M., Pallua, N., & Dooley, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502071200 · Cited by 90
Trensz, F., Haroun, S., Cloutier, A., Richter, M. V., & Grenier, G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2010 · Cited by 86
β-Catenin-Independent Wnt Pathways: Signals, Core Proteins, and Effectors
James, R. G., Conrad, W. H., & Moon, R. T. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-59745-249-6_10 · Cited by 70
Dickkopf-1: a suitable target for the management of myeloma bone disease
Gavriatopoulou, M., Dimopoulos, M.-A., Christoulas, D., Migkou, M., Iakovaki, M., Gkotzamanidou, M., & Terpos, E. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903025770 · Cited by 68
TGF-β modulates β-Catenin stability and signaling in mesenchymal proliferations
Amini‐Nik, S., ابراهیم, ر. پ., Dam, K. V., Cassiman, J., & Tejpar, S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.05.024 · Cited by 64
Wnt Pathway in Pulmonary Fibrosis in the Bleomycin Mouse Model
Liu, L., Carron, B., Yee, H. T., Yie, T.-A., Hajjou, M., & Rom, W. N. (2009) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v28.i2.20 · Cited by 57
Colwell, A. S., Krummel, T. M., Longaker, M. T., & Lorenz, H. P. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000218708.16909.31 · Cited by 47
Blockade of the Effects of TGF-β1 on Mesangial Cells by Overexpression of Smad7
Chen, R., Huang, C., Morinelli, T. A., Trojanowska, M., & Paul, R. V. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134887 · Cited by 43
Ballmer, T. T., & Brennenstuhl, W. (1981) · Springer series in language and communication · doi:10.1007/978-3-642-67758-8_6 · Cited by 19
Gordon, A. C., Kiss‐Toth, E., Stockley, I., Eastell, R., & Wilkinson, J. M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25041 · Cited by 4
Cited by
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00762-6 · Cited by 2,519
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Metadata
- Authors
- Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., Schneider, H., Sadowski, A., Riener, M.-O., MacDougald, O. A., Distler, O., Schett, G., & Distler, J. H. W.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Michigan (US)
- University Hospital Zurich (CH)
- Corresponding author
- Distler, Jörg H.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2012-03-13
- Volume
- 3
- Issue
- 1
- Pages
- 735-735
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3316881
- OpenAlex
- W2059114286
- Cited by
- 843
- References
- 61
- Citations by year
- 2026: 45 · 2025: 61 · 2024: 68 · 2023: 57 · 2022: 74 · 2021: 58 · 2020: 67 · 2019: 60 · 2018: 59 · 2017: 65 · 2016: 59 · 2015: 54 · 2014: 57 · 2013: 43 · 2012: 16
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Bundesministerium für Bildung und Forschung (01EC1002D)
- National Institutes of Health (DK62876)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK092759, DK-51563, N02 DK062876, DK92759, R01DK051563, R01DK062876, P30DK020572)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- Wnt/β-catenin signaling, TGF-beta signaling, fibrosis, DKK1, p38 MAPK, fibroblast activation, skin fibrosis, TGF-beta type I receptor, extracellular matrix synthesis, fibrotic diseases, pathway interactions
- MeSH terms
- Adult, Animals, Cells, Cultured, Extracellular Matrix, Female, Fibrosis, Humans, Male, Mice, Transgenic, Middle Aged, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta, RNA Interference, RNA, Small Interfering, Intercellular Signaling Peptides and Proteins, p38 Mitogen-Activated Protein Kinases, Wnt Proteins, Mice, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.